病原体灭菌系统市场－全球产业规模、份额、趋势、机会和预测，按类型、应用、产品、最终用户、地区和竞争细分，2020 年至 2030 年

2024年，全球病原体灭活系统市场价值为7.1906亿美元，预计在预测期内将呈现显着成长，到2030年复合年增长率将达到8.00%。病原体是能够引起人体严重感染和疾病的有害微生物。为了降低输血过程中传播感染的风险，人们采用了病原体灭活系统。该系统包含一系列旨在灭活或去除血液和血液製品（例如血浆、红血球和血小板）中病原体的製程和技术。在为免疫系统较弱的患者输血时，确保这些产品的安全性尤其重要，因为受污染的血液可能引发不良的免疫反应或导致进一步的併发症。

病原体灭活的主要目标是透过最大限度地降低输血传播感染的风险来增强血液供应的安全性。为了实现这一目标，人们采用了多种先进方法。其中，紫外线 (UV) 和光化学处理被广泛应用。这些技术透过破坏病原体的核酸（DNA 或 RNA）来发挥作用，从而有效地阻止其复製和造成危害。光化学处理通常涉及在血液製品中添加一种感光化合物，这种化合物在暴露于紫外线下时会与病原体的遗传物质相互作用，使其失效。除了基于紫外线的技术外，过滤方法也在病原体灭活中发挥关键作用。这些方法包括让血液通过专门设计的细菌过滤器，其孔径足够小，可以在物理上阻挡病原体，同时允许血液的主要成分通过。这些方法共同作用，有助于确保输血尽可能安全且无病原体。透过实施病原体灭活技术，医疗保健系统可以显着降低输血过程中疾病传播的风险，从而保障患者健康并改善预后，尤其是对于免疫功能低下的患者。

关键市场驱动因素

提高对感染控制的认识与重视

主要市场挑战

技术复杂性与成本

主要市场趋势

先进技术与创新

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：全球病原体灭活系统市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 依类型（血小板病原体减少、血浆病原体减少）
  • 依应用（病毒、真菌、细菌）
  • 按产品（自动化、半自动化）
  • 按最终使用者（医院和诊所、门诊护理中心、血库、其他）
  • 按地区（北美、欧洲、亚太、南美、中东和非洲）
  • 按公司分类（2024）
• 市场地图

第六章：北美病原体灭活系统市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲病原体灭活系统市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 法国
  • 德国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太病原体灭活系统市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：南美洲病原体灭活系统市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第十章：中东和非洲病原体灭活系统市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 近期发展
• 併购
• 产品发布

第 13 章：全球病原体减少系统市场：SWOT 分析

第 14 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品的威胁

第 15 章：竞争格局

第 15 章：1 Terumo BCT, Inc.

第 15 章：2 Macopharma SA。

第 15 章：3 Cerus 公司。

第 15 章：4 AngioDynamics, Inc.

第 15 章：5 Octapharma AG。

第 16 章：策略建议

第17章调查会社について・免责事项

Global Pathogen Reduction Systems Market was valued at USD 719.06 Million in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 8.00% through 2030. Pathogens are harmful microorganisms capable of causing serious infections and diseases in the human body. To mitigate the risk of transmitting infections during transfusions, a pathogen reduction system is utilized. This system includes a range of processes and technologies designed to inactivate or remove pathogens from blood and blood products such as plasma, red blood cells, and platelets. Ensuring the safety of these products is especially critical when transfusing patients with weakened immune systems, as contaminated blood could trigger adverse immune responses or lead to further complications.

The main goal of pathogen reduction is to enhance the safety of the blood supply by minimizing the risk of transfusion-transmitted infections. Several advanced methods are employed to achieve this. Among them, ultraviolet (UV) light and photochemical treatments are widely used. These techniques work by damaging the nucleic acids (DNA or RNA) of pathogens, effectively preventing them from replicating and causing harm. Photochemical treatments often involve adding a photosensitive compound to the blood product, which, when exposed to UV light, interacts with the pathogen's genetic material, rendering it non-functional. In addition to UV-based technologies, filtration methods also play a key role in pathogen reduction. These involve passing blood through specialized bacterial filters designed with pore sizes small enough to physically block pathogens while allowing essential blood components to pass through. Together, these methods help ensure that transfused blood is as safe and pathogen-free as possible. By implementing pathogen reduction technologies, healthcare systems can significantly reduce the risk of disease transmission during transfusion, thereby safeguarding patient health and improving outcomes, especially for immunocompromised individuals.

Key Market Drivers

Increasing Awareness and Emphasis on Infection Control

Increasing awareness and emphasis on infection control have a significant influence on the growth of the global pathogen reduction systems market. As awareness about the risks and consequences of infections grows, there is a higher demand for effective infection control solutions. For instance, on June 2025, Cerus Corporation (NASDAQ:CERS) participated in the Goldman Sachs 46th Annual Global Healthcare Conference. CEO Obi Greenman highlighted the company's strategic focus on pathogen reduction technologies and the growing adoption of its INTERCEPT blood system. Despite a solid financial foundation and market leadership, Cerus continues to navigate challenges related to expanding market penetration and securing regulatory approvals. Pathogen reduction systems are essential tools in combating the spread of infections in various settings, including healthcare facilities, food processing industries, and public spaces. The emphasis on infection control drives the adoption of these systems, resulting in market growth. Governments and regulatory bodies worldwide have implemented stringent standards and guidelines related to infection control. Compliance with these regulations necessitates the use of pathogen reduction systems in various industries. The awareness of these requirements drives organizations to invest in and implement these systems to ensure compliance and maintain public health and safety. HAIs pose a significant risk to patients, healthcare providers, and the healthcare system as a whole. Increasing awareness of the prevalence and impact of HAIs has led to a greater emphasis on infection control in healthcare settings. Pathogen reduction systems play a crucial role in minimizing the risk of HAIs by eliminating or reducing the presence of pathogens. The focus on infection control in healthcare drives the demand for these systems. Outbreaks of infectious diseases, such as the COVID-19 pandemic, have highlighted the critical importance of infection control and prevention. Governments, healthcare organizations, and other institutions are now prioritizing the preparedness and response to such outbreaks. Pathogen reduction systems are considered essential tools in mitigating the spread of diseases during outbreaks, resulting in increased adoption and market growth. Consumers are becoming more conscious of the risks associated with infections, especially in the context of food safety and public spaces. They expect businesses and establishments to prioritize infection control measures and provide safe environments. This consumer awareness and expectation drive the demand for pathogen reduction systems in industries such as food processing, hospitality, and public facilities. Increased awareness of the importance of infection control has led to collaborative efforts among governments, healthcare organizations, and educational institutions to educate the public about best practices. These initiatives raise awareness about the role of pathogen reduction systems and their effectiveness in preventing the spread of infections. As a result, there is greater acceptance and adoption of these systems, contributing to market growth.

Key Market Challenges

Technological Complexity and Cost

Developing and implementing effective pathogen reduction technologies can be complex and costly. The research, development, and testing of these systems require significant resources, which can impact their affordability and accessibility, especially for small-scale producers. Adhering to strict regulatory standards and guidelines is crucial for pathogen reduction systems, particularly in the food industry. Meeting and maintaining these regulations can be challenging due to evolving standards and variations in requirements across different regions and countries. Introducing new pathogen reduction methods can sometimes face resistance from consumers who might be concerned about the impact of these processes on the sensory qualities, nutritional value, or overall safety of the products.

Key Market Trends

Advanced Technologies and Innovation

The pathogen reduction systems market is likely to see continuous advancements in technologies such as nanotechnology, advanced filtration, and new chemical treatments. These innovations could lead to more efficient and targeted pathogen reduction methods. The integration of Internet of Things (IoT) technology and smart sensors could enable real-time monitoring, data collection, and control of pathogen reduction processes. This could enhance system efficiency, reduce waste, and improve response times to potential issues. Pathogen reduction systems could be integrated more seamlessly into global supply chains, ensuring the safety of products as they move across various stages of production, distribution, and consumption.

Key Market Players

• Terumo BCT, Inc.
• Macopharma SA.
• Cerus Corporation.
• AngioDynamics, Inc.
• Octapharma AG.

Report Scope:

In this report, the Global Pathogen Reduction Systems Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Pathogen Reduction Systems Market, By Type:

• Platelet Pathogen Reduction
• Plasma Pathogen Reduction

Pathogen Reduction Systems Market, By Application:

• Viruses
• Fungi
• Bacteria

Pathogen Reduction Systems Market, By Product:

• Automated
• Semi-Automated

Pathogen Reduction Systems Market, By End User:

• Hospitals & Clinics
• Ambulatory Care centers
• Blood Banks
• Others

Pathogen Reduction Systems Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Pathogen Reduction Systems Market.

Available Customizations:

Global Pathogen Reduction Systems market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Pathogen Reduction Systems Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Platelet Pathogen Reduction, Plasma Pathogen Reduction)
  • 5.2.2. By Application (Viruses, Fungi, Bacteria)
  • 5.2.3. By Product (Automated, Semi-Automated)
  • 5.2.4. By End User (Hospitals & Clinics, Ambulatory Care centers, Blood Banks, Others)
  • 5.2.5. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
  • 5.2.6. By Company (2024)
• 5.3. Market Map

6. North America Pathogen Reduction Systems Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type (Platelet Pathogen Reduction, Plasma Pathogen Reduction)
  • 6.2.2. By Application (Viruses, Fungi, Bacteria)
  • 6.2.3. By Product (Automated, Semi-Automated)
  • 6.2.4. By End User (Hospitals & Clinics, Ambulatory Care centers, Blood Banks, Others)
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Pathogen Reduction Systems Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By Product
      • 6.3.1.2.4. By End User
  • 6.3.2. Canada Pathogen Reduction Systems Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By Product
      • 6.3.2.2.4. By End User
  • 6.3.3. Mexico Pathogen Reduction Systems Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By Product
      • 6.3.3.2.4. By End User

7. Europe Pathogen Reduction Systems Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type (Platelet Pathogen Reduction, Plasma Pathogen Reduction)
  • 7.2.2. By Application (Viruses, Fungi, Bacteria)
  • 7.2.3. By Product (Automated, Semi-Automated)
  • 7.2.4. By End User (Hospitals & Clinics, Ambulatory Care centers, Blood Banks, Others)
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Pathogen Reduction Systems Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By Product
      • 7.3.1.2.4. By End User
  • 7.3.2. Germany Pathogen Reduction Systems Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By Product
      • 7.3.2.2.4. By End User
  • 7.3.3. United Kingdom Pathogen Reduction Systems Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By Product
      • 7.3.3.2.4. By End User
  • 7.3.4. Italy Pathogen Reduction Systems Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By Product
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Pathogen Reduction Systems Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By Product
      • 7.3.5.2.4. By End User

8. Asia-Pacific Pathogen Reduction Systems Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type (Platelet Pathogen Reduction, Plasma Pathogen Reduction)
  • 8.2.2. By Application (Viruses, Fungi, Bacteria)
  • 8.2.3. By Product (Automated, Semi-Automated)
  • 8.2.4. By End User (Hospitals & Clinics, Ambulatory Care centers, Blood Banks, Others)
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Pathogen Reduction Systems Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By Product
      • 8.3.1.2.4. By End User
  • 8.3.2. India Pathogen Reduction Systems Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By Product
      • 8.3.2.2.4. By End User
  • 8.3.3. Japan Pathogen Reduction Systems Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By Product
      • 8.3.3.2.4. By End User
  • 8.3.4. South Korea Pathogen Reduction Systems Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By Product
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Pathogen Reduction Systems Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By Product
      • 8.3.5.2.4. By End User

9. South America Pathogen Reduction Systems Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type (Platelet Pathogen Reduction, Plasma Pathogen Reduction)
  • 9.2.2. By Application (Viruses, Fungi, Bacteria)
  • 9.2.3. By Product (Automated, Semi-Automated)
  • 9.2.4. By End User (Hospitals & Clinics, Ambulatory Care centers, Blood Banks, Others)
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Pathogen Reduction Systems Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By Product
      • 9.3.1.2.4. By End User
  • 9.3.2. Argentina Pathogen Reduction Systems Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By Product
      • 9.3.2.2.4. By End User
  • 9.3.3. Colombia Pathogen Reduction Systems Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By Product
      • 9.3.3.2.4. By End User

10. Middle East and Africa Pathogen Reduction Systems Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type (Platelet Pathogen Reduction, Plasma Pathogen Reduction)
  • 10.2.2. By Application (Viruses, Fungi, Bacteria)
  • 10.2.3. By Product (Automated, Semi-Automated)
  • 10.2.4. By End User (Hospitals & Clinics, Ambulatory Care centers, Blood Banks, Others)
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Pathogen Reduction Systems Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By Product
      • 10.3.1.2.4. By End User
  • 10.3.2. Saudi Arabia Pathogen Reduction Systems Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By Product
      • 10.3.2.2.4. By End User
  • 10.3.3. UAE Pathogen Reduction Systems Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By Product
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Global Pathogen Reduction Systems Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

15.1 Terumo BCT, Inc.

15.2 Macopharma SA.

15.3 Cerus Corporation.

15.4 AngioDynamics, Inc.

15.5 Octapharma AG.

16. Strategic Recommendations

17. About Us & Disclaimer